• Home
  • About Us
    • Who we are
    • Our Early History
    • Technology
    • Target Markets
      • Venous and pressure ulcers
      • Other Applications
    • Business Model
    • Licensing
    • Clinical Trial
    • Publications & Presentations
    • Company Milestones
    • Focus
  • The Company
    • Board & Management
      • Paul Wright
      • Mark Richardson
      • George Baumanis
      • Stuart Usher
  • Advisory Team
    • Intellectual Property
      • Vaughan Barlow
      • Tom Boyce
      • Audrey Yap
      • Yvette Flanigan
    • Principal Advisor
      • Mark Woolley
    • Medical and Scientific Advisory Committee
      • James Fries
      • Michael Woodward
    • Scientific
      • Richard Lipscombe
    • Clinical
      • Geoffrey Mitchell
    • Health Economics
      • Nicholas Graves
  • Media
  • Links
  • Members Log in
  • Contact Us

News Headlines

> 18/01/10
Phoenix Eagle commences clinical trial.

> 01/12/09
OPAL A-1001 clinical trial has been approved by the Human Research Ethics Committee of the Austin Hospital.

Our Contact Details

Phoenix Eagle Company Pty Ltd

PO Box 502
Hillarys 6025
Western Australia

Tel: +61 8 9367 4419
Mob: +61 (0) 439 523 424
Email: business@phoenixeaglecompany.com

The Phoenix Eagle Company Pty Ltd website is proudly maintained by NetBiz Enterprises.